- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 972506, 6 pages
Helminth Excreted/Secreted Antigens Repress Expression of LPS-Induced Let-7i but Not miR-146a and miR-155 in Human Dendritic Cells
1Biomedicine Unit, Facultad de Estudios Superiores Iztacala, UNAM, Avenida de los Barrios No. 1 Col. Los Reyes Iztacala, 54090 Tlalnepantla, MEX, Mexico
2Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano No. 1 Col. Sección XVI, 140080 Tlalpan, DF, Mexico
3Blood Bank, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano No. 1 Col. Sección XVI, 140080 Tlalpan, DF, Mexico
4Department of Health Care, Universidad Autónoma Metropolitana Xochimilco, Calzada del Hueso No. 1100 Col. Villa Quietud, 04960 Coyoacán, DF, Mexico
Received 7 August 2012; Accepted 1 October 2012
Academic Editor: Miriam Rodríguez-Sosa
Copyright © 2013 Luis I. Terrazas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004.
- S. T. Hashimi, J. A. Fulcher, M. H. Chang, L. Gov, S. Wang, and B. Lee, “MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation,” Blood, vol. 114, no. 2, pp. 404–414, 2009.
- D. S. Rao, R. M. O'Connell, A. A. Chaudhuri, Y. Garcia-Flores, T. L. Geiger, and D. Baltimore, “MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1,” Immunity, vol. 33, no. 1, pp. 48–59, 2010.
- S. A. Muljo, K. Mark Ansel, C. Kanellopoulou, D. M. Livingston, A. Rao, and K. Rajewsky, “Aberrant T cell differentiation in the absence of Dicer,” The Journal of Experimental Medicine, vol. 202, no. 2, pp. 261–269, 2005.
- G. Liu, A. Friggeri, Y. Yang, Y. J. Park, Y. Tsuruta, and E. Abraham, “miR-147, a microRNA that is induced upon toll-like receptor stimulation, regulates murine macrophage inflammatory responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15819–15824, 2009.
- T. X. Lu, J. Hartner, E.-J. Lim et al., “MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-γ pathway, Th1 polarization, and the severity of delayed-type hypersensitivity,” The Journal of Immunology, vol. 187, no. 6, pp. 3362–3373, 2011.
- E. Vigorito, K. L. Perks, C. Abreu-Goodger et al., “microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells,” Immunity, vol. 27, no. 6, pp. 847–859, 2007.
- R. M. O'Connell, D. S. Rao, A. A. Chaudhuri, and D. Baltimore, “Physiological and pathological roles for microRNAs in the immune system,” Nature Reviews Immunology, vol. 10, no. 2, pp. 111–122, 2010.
- C. H. Lecellier, P. Dunoyer, K. Arar et al., “A cellular microRNA mediates antiviral defense in human cells,” Science, vol. 308, no. 5721, pp. 557–560, 2005.
- G. M. Zeiner, K. L. Norman, J. M. Thomson, S. M. Hammond, and J. C. Boothroyd, “Toxoplasma gondii infection specifically increases the levels of key host microRNAs,” PLoS ONE, vol. 5, no. 1, Article ID e8742, 2010.
- G. Hu, R. Zhou, J. Liu, A. Y. Gong, and X. M. Chen, “MicroRNA-98 and let-7 regulate expression of suppressor of cytokine signaling 4 in biliary epithelial cells in response to Cryptosporidium parvum infection,” Journal of Infectious Diseases, vol. 202, no. 1, pp. 125–135, 2010.
- C. A. Terrazas, F. Sánchez-Muñoz, A. M. Mejí-Domínguez, et al., “Cestode antigens induce a tolerogenic-like phenotype and inhibit LPS in-flammatory responses in human dendritic cells,” International Journal of Biological Sciences, vol. 7, no. 9, pp. 1391–1400, 2011.
- B. Pulendran, K. Palucka, and J. Banchereau, “Sensing pathogens and tuning immune responses,” Science, vol. 293, no. 5528, pp. 253–256, 2001.
- F. Sallusto, B. Palermo, D. Lenig et al., “Distinct patterns and kinetics of chemokine production regulate dendritic cell function,” European Journal of Immunology, vol. 29, no. 5, pp. 1617–1625, 1999.
- H. B. Mou, M. F. Lin, H. Huang, and Z. Cai, “Transforming growth factor-β1 modulates lipopolysaccharide-induced cytokine/chemokine production and inhibits nuclear factor-κB, extracellular signal-regulated kinases and p38 activation in dendritic cells in mice,” Transplantation Proceedings, vol. 43, no. 5, pp. 2049–2052, 2011.
- C. Lu, X. Huang, X. Zhang et al., “miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1,” Blood, vol. 117, no. 16, pp. 4293–4303, 2011.
- M. Zhang, F. Liu, H. Jia et al., “Inhibition of microRNA let-7i depresses maturation and functional state of dendritic cells in response to lipopolysaccharide stimulation via targeting suppressor of cytokine signaling 1,” The Journal of Immunology, vol. 187, no. 4, pp. 1674–1683, 2011.
- P. Jin, T. H. Han, J. Ren et al., “Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies,” Journal of Translational Medicine, vol. 8, article 4, 2010.
- B. J. H. Jansen, I. E. Sama, D. Eleveld-Trancikova et al., “MicroRNA genes preferentially expressed in dendritic cells contain sites for conserved transcription factor binding motifs in their promoters,” BMC Genomics, vol. 12, article 330, 2011.
- M. Ortiz, F. Schreiber, S. Benitez et al., “Effects of chronic ascariasis and trichuriasis on cytokine production and gene expression in human blood: a cross-sectional study,” PLoS Neglected Tropical Diseases, vol. 5, no. 6, Article ID e1157, 2011.
- K. M. Pauley, M. Satoh, A. L. Chan, M. R. Bubb, W. H. Reeves, and E. K. L. Chan, “Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients,” Arthritis Research and Therapy, vol. 10, no. 4, article R101, 2008.
- A. Androulidaki, D. Iliopoulos, A. Arranz et al., “The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs,” Immunity, vol. 31, no. 2, pp. 220–231, 2009.
- X. M. Chen, P. L. Splinter, S. P. O'Hara, and N. F. LaRusso, “A cellular micro-RNA, let-7i, regulates toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection,” The Journal of Biological Chemistry, vol. 282, no. 39, pp. 28929–28938, 2007.
- F. El-Assaad, C. Hempel, V. Combes et al., “Differential microRNA expression in experimental cerebral and noncerebral malaria,” Infection and Immunity, vol. 79, no. 6, pp. 2379–2384, 2011.
- J. L. Eyles, D. Metcalf, M. J. Grusby, D. J. Hilton, and R. Starr, “Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1,” The Journal of Biological Chemistry, vol. 277, no. 46, pp. 43735–43740, 2002.
- K. Evel-Kabler, X. T. Song, M. Aldrich, X. F. Huang, and S. Y. Chen, “SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling,” The Journal of Clinical Investigation, vol. 116, no. 1, pp. 90–100, 2006.
- S. P. O'Hara, P. L. Splinter, G. B. Gajdos et al., “NFκB p50-CCAAT/enhancer-binding protein β (C/EBPβ)-mediated transcriptional repression of microRNA let-7i following microbial infection,” The Journal of Biological Chemistry, vol. 285, no. 1, pp. 216–225, 2010.